期刊
ADVANCED MATERIALS
卷 33, 期 21, 页码 -出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/adma.202007421
关键词
chimeric antigen receptor T‐ cell therapy; high‐ aspect‐ ratio nanostructures; microfluidics; nanoparticles; transfection techniques
类别
资金
- NUS Start-up grant [R-397-000-358-133]
- Institute for Health Innovation Technology [R-722-018-004-731]
- NUS Research Scholarships
Traditional and emerging materials for immune cell transfection, their strengths and limitations, and commercial development of these tools are discussed. A list of in vitro and in vivo assays, along with relevant protocols, is recommended to enhance the characterization of transfection techniques and uptake by the clinical community. The overall aim is to motivate the development of novel materials to meet rising demand in transfection for clinical CAR-T cell manufacturing.
Chimeric antigen receptor T cell (CAR-T) therapy holds great promise for preventing and treating deadly diseases such as cancer. However, it remains challenging to transfect and engineer primary immune cells for clinical cell manufacturing. Conventional tools using viral vectors and bulk electroporation suffer from low efficiency while posing risks like viral transgene integration and excessive biological perturbations. Emerging techniques using microfluidics, nanoparticles, and high-aspect-ratio nanostructures can overcome these challenges, and on top of that, provide universal and high-throughput cargo delivery. Herein, the strengths and limitations of traditional and emerging materials for immune cell transfection, and commercial development of these tools, are discussed. To enhance the characterization of transfection techniques and uptake by the clinical community, a list of in vitro and in vivo assays to perform, along with relevant protocols, is recommended. The overall aim, herein, is to motivate the development of novel materials to meet rising demand in transfection for clinical CAR-T cell manufacturing.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据